I am pleased to join the committee this morning to discuss the regulations. It is the Scottish Government’s clear position that the interests of Scotland would be best served by remaining in the European Union. Recent events in Whitehall have served only to strengthen that view. However, as a responsible Government, we have a duty to make the necessary preparations to ensure that the Scottish statute book remains operable to help to mitigate the considerable damage that a no-deal Brexit would cause.
At present, under the European Union cross-border healthcare directive, European Economic Area citizens have the right to obtain healthcare services in other EEA countries. However, the treatment must be the same as, or equivalent to, the treatment that is provided by the state in their country of affiliation. The patient pays for the treatment up front and may claim reimbursement, limited to the amount that the treatment would cost had it been provided by the state at home—in Scotland, that would be treatment on the NHS.
As healthcare is devolved, the National Health Service (Cross-Border Health Care) (Scotland) Regulations 2013 implemented the directive in Scotland where necessary. The regulations provide a legal basis for the NHS to apply the need for prior authorisation for expensive specialist treatment. They also limit the amount of reimbursement to the cost to the NHS had the treatment been provided here.
Importantly, the home state retains responsibility for the healthcare that it funds on a cross-border basis. If the treatment is not available on the NHS in Scotland, patients cannot use the directive to receive it in another EEA country and claim reimbursement from the NHS in turn.
The Cross-border Health Care (EU Exit) (Scotland) (Amendment etc) Regulations 2019 are taken from powers within the European Union (Withdrawal) Act 2018. They correct deficiencies that would arise from the UK’s withdrawal from the EU without a deal by modifying the 2013 regulations. England, Wales and Northern Ireland are introducing similar regulations.
The regulations protect patients in a transitional position and enable continuation of cross-border healthcare arrangements in those countries with which the UK has established continued reciprocal arrangements, maintaining the provisions in the directive that gives EEA citizens the choice to travel for healthcare.
Maintaining effective access to cross-border healthcare abroad requires basic reciprocal agreements to ensure that the existing EU framework is maintained in participating countries. Therefore, the regulations terminate access to cross-border healthcare with countries where there is no longer a reciprocal agreement. As reciprocal healthcare arrangements are applied on UK-wide basis, the Secretary of State for Health will maintain a list of countries that reach agreement to maintain the current reciprocal arrangements with the UK until 31 December 2020.
The regulations protect, as far as possible, key groups of patients in a transitional situation on exit day, irrespective of any reciprocal agreement being in place. Examples include individuals who obtain prior authorisation for planned treatment before exit day but who have not yet obtained treatment; individuals who accessed healthcare abroad prior to exit day but who have not yet completed their treatment or sought reimbursement; and UK state pensioners from Scotland who are living in other EEA countries and need to access healthcare provided by the NHS while they are in Scotland.
These time-limited measures aim to prevent, as far as possible, without reciprocal agreements, a sudden loss of overseas healthcare rights for Scottish residents and pensioners from Scotland residing in the EEA. We consider the amendments to be technical for the most part.
I hope that members will agree that, as part of the Scottish Government’s overall programme of legislative contingency planning for Brexit, the Cross-border Health Care (EU Exit) (Scotland) (Amendment etc) Regulations 2019 provide necessary changes to protect Scottish residents’ rights to access cross-border healthcare in other EEA countries, as far as that can be achieved.
We are happy to answer questions.